A generalized pustular psoriasis flare after CoronaVac COVID-19 vaccination: Case report

Nahide Onsun ¹ * , Gökhan Kaya ¹ , Bengisu Güçkan Işık ¹ , Begüm Güneş ¹

Cited by CrossRef: 47

1- Puig L, Choon S, Gottlieb A, Marrakchi S, Prinz J, Romiti R, Tada Y, von Bredow D, Gooderham M. Generalized pustular psoriasis: A global Delphi consensus on clinical course, diagnosis, treatment goals and disease management. Acad Dermatol Venereol. 2023;37(4):737 [Crossref]

2- Olisova O, Vovdenko K, Mak D, Mishin S. Polymorphic dermal vasculitis flare up after COVID-19: case report. Russian Journal of Skin and Venereal Diseases. 2021;24(6):573 [Crossref]

3- Aryanian Z, Balighi K, Hatami P, Goodarzi A, Mohandesi N, Afshar Z. SARS‐CoV‐2 vaccination and practical points in psoriasis patients: A narrative review. Dermatologic Therapy. 2022;35(5) [Crossref]

4- Kandimalla R, Chakraborty P, Vallamkondu J, Chaudhary A, Samanta S, Reddy P, De Feo V, Dewanjee S. Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges. Biomedicines. 2021;9(11):1740 [Crossref]

5- Diotallevi F, Campanati A, Radi G, Martina E, Rizzetto G, Barbadoro P, D’Errico M, Offidani A. Vaccines Against SARS-CoV-2 in Psoriasis Patients on Immunosuppressive Therapy: Implications of Vaccination Nationwide Campaign on Clinical Practice in Italy. Dermatol Ther (Heidelb). 2021;11(6):1889 [Crossref]

6- Al-Battat R, Al-Aish S, Al Sakini A, Allawi M. Systemic and cutaneous side effects of COVID-19 vaccines in Iraq, A cross-sectional study. Clinical Epidemiology and Global Health. 2024;27:101613 [Crossref]

7- Kamal K, Riew G, Hijaz B, Helfgott S, Laga A, Nambudiri V. Generalized pustular psoriasis‐like widespread eruption following COVID‐19 infection in a patient with spondyloarthropathy on adalimumab. Experimental Dermatology. 2024;33(1) [Crossref]

8- Arifin A, Hengky A, Widjaja M, Wijaya L. New-Onset and Exacerbation of Psoriasis following COVID-19 Vaccination: A Systematic Review of Case Reports and Case Series. 2023;68(6):724 [Crossref]

9- Elewski B, Lebwohl M. Exploring the Chronic Nature of Generalized Pustular Psoriasis [Podcast]. CCID. 2024;Volume 17:2487 [Crossref]

10- Wang Q, Lv C, Han X, Shen M, Kuang Y. A Web-Based Survey on Factors for Unvaccination and Adverse Reactions of SARS-CoV-2 Vaccines in Chinese Patients with Psoriasis. JIR. 2021;Volume 14:6265 [Crossref]

11- Potestio L, Battista T, Cacciapuoti S, Ruggiero A, Martora F, Fornaro L, Camela E, Megna M. New Onset and Exacerbation of Psoriasis Following COVID-19 Vaccination: A Review of the Current Knowledge. Biomedicines. 2023;11(8):2191 [Crossref]

12- Chhabra N, George A. A Case of de novo Annular-plaque Type Psoriasis Following Oxford- AstraZeneca COVID-19 Vaccination. CDS. 2023;18(4):584 [Crossref]

13- Nagrani P, Jindal R, Goyal D. Onset/flare of psoriasis following the ChAdOx1 nCoV ‐19 Corona virus vaccine ( Oxford‐AstraZeneca /Covishield): Report of two cases . Dermatologic Therapy. 2021;34(5) [Crossref]

14- Narang T, Sharma A, Bhandari A, Handa S, Dogra S. SARS-CoV-19 and Generalised Pustular Psoriasis: A Lethal Combination. 2023;68(6):726 [Crossref]

15- Niebel D, Novak N, Wilhelmi J, Ziob J, Wilsmann-Theis D, Bieber T, Wenzel J, Braegelmann C. Cutaneous Adverse Reactions to COVID-19 Vaccines: Insights from an Immuno-Dermatological Perspective. Vaccines. 2021;9(9):944 [Crossref]

16- Karampinis E, Goudouras G, Ntavari N, Bogdanos D, Roussaki-Schulze A, Zafiriou E. Serum vitamin D levels can be predictive of psoriasis flares up after COVID-19 vaccination: a retrospective case control study. Front Med. 2023;10 [Crossref]

17- Wu P, Huang I, Wang C, Tsai C, Chung W, Chen C. New Onset and Exacerbations of Psoriasis Following COVID-19 Vaccines: A Systematic Review. Am J Clin Dermatol. 2022;23(6):775 [Crossref]

18- Shakoei S, Kalantari Y, Nasimi M, Tootoonchi N, Ansari M, Razavi Z, Etesami I. Cutaneous manifestations following COVID‐19 vaccination: A report of 25 cases. Dermatologic Therapy. 2022;35(8) [Crossref]

19- Fujita H, Gooderham M, Romiti R. Diagnosis of Generalized Pustular Psoriasis. Am J Clin Dermatol. 2022;23(S1):31 [Crossref]

20- Bostan E, Elmas L, Yel B, Yalici‐Armagan B. Exacerbation of plaque psoriasis after inactivated and BNT162b2 mRNA COVID‐19 vaccines: A report of two cases. Dermatologic Therapy. 2021;34(6) [Crossref]

21- Salehi S, Sadeghi S, Kalantari Y, Goodarzi A. A Systematic Review of Histopathologic Surveys on Mucocutaneous Biopsies in Patients Developed COVID-19 Vaccine-Related Dermatologic Manifestations. 2023;45(1):1 [Crossref]

22- Dayani D, Rokhafrouz H, Balighi K. Generalized Pustular Psoriasis Flare-Up after Both Doses of BBIBP-CorV Vaccination in a Patient under Adalimumab Treatment: A Case Report. Case Rep Dermatol. 2023;15(1):61 [Crossref]

23- Rouai M, Slimane M, Sassi W, Alaoui F, Chelly I, Mokni M. Pustular rash triggered by Pfizer‐BioNTech COVID‐19 vaccination: A case report. Dermatologic Therapy. 2022;35(6) [Crossref]

24- Frioui R, Chamli A, Zaouak A, Hlel I, Khanchel F, Fenniche S, Hammami H. A case of new‐onset acute generalized pustular psoriasis following Pfizer‐BioNTech COVID ‐19 vaccine . Dermatologic Therapy. 2022;35(6) [Crossref]

25- Ye S, Sun H, Xu Z, Xu B, Wu N, Wu J. A study of the efficacy and safety of plaque psoriasis treatment by TNF‐α and IL‐17A inhibitor biologics in patients who received the inactivated SARS‐CoV‐2 vaccine. Immunity Inflam & Disease. 2023;11(7) [Crossref]

26- Katsuie S, Nakamura K, Ogawa E, Arakura F, Okuyama R. Relapse of Palmoplantar Pustulosis Following COVID-19 Vaccination. 2022; [Crossref]

27- Durmaz I, Turkmen D, Altunisik N, Toplu S. Exacerbations of generalized pustular psoriasis, palmoplantar psoriasis, and psoriasis vulgaris after mRNA COVID ‐19 vaccine: A report of three cases . Dermatologic Therapy. 2022;35(4) [Crossref]

28- Ayatollahi A, Hosseini H, Firooz R, Firooz A. COVID ‐19 vaccines: What dermatologists should know? . Dermatologic Therapy. 2021;34(5) [Crossref]

29- Genovese G, Moltrasio C, Cassano N, Maronese C, Vena G, Marzano A. Pustular Psoriasis: From Pathophysiology to Treatment. Biomedicines. 2021;9(12):1746 [Crossref]

30- Romagnuolo M, Pontini P, Muratori S, Marzano A, Moltrasio C. De novo annular pustular psoriasis following mRNA COVID‐19 vaccine. Acad Dermatol Venereol. 2022;36(8) [Crossref]

31- Campanati A, Diotallevi F, Martina E, Radi G, Offidani A. Treatment of Moderate to Severe Psoriasis during the COVID-19 Pandemic: Lessons Learned and Opportunities. JCM. 2022;11(9):2422 [Crossref]

32- Yatsuzuka K, Murakami M, Kuroo Y, Fukui M, Yoshida S, Muto J, Shiraishi K, Sayama K. Flare‐up of generalized pustular psoriasis combined with systemic capillary leak syndrome after coronavirus disease 2019 mRNA vaccination. The Journal of Dermatology. 2022;49(4):454 [Crossref]

33- Ergun T, Hosgoren Tekin S, Apti Sengun O, Akin Cakici O, Seckin D, Adiay C, Enul H, Yilmaz S, Ay P, Haklar G, Sili U. Immunogenicity, efficacy, and safety of CoronaVac and Pfizer/BioNTech mRNA vaccines in patients with psoriasis receiving systemic therapies: A prospective cohort study. Vaccine. 2023;41(29):4287 [Crossref]

34- Karampinis E, Papadopoulou M, Chaidaki K, Georgopoulou K, Magaliou S, Roussaki Schulze A, Bogdanos D, Zafiriou E. Plaque Psoriasis Exacerbation and COVID-19 Vaccination: Assessing the Characteristics of the Flare and the Exposome Parameters. Vaccines. 2024;12(2):178 [Crossref]

35- Durmus O, Akdogan N, Karadag O, Gokoz O. Erythroderma related with the first dose of Pfizer‐BioNTech BNT16B2b2 COVID‐19 mRNA vaccine in a patient with psoriasis. Dermatologic Therapy. 2022;35(5) [Crossref]

36- Farouk S, Raslan G, El Waseef M. Psoriasis with Sputnik V vaccine, a potential triggering factor. Dermatologic Therapy. 2022;35(9) [Crossref]

37- Perna D, Jones J, Schadt C. Acute generalized pustular psoriasis exacerbated by the COVID-19 vaccine. JAAD Case Reports. 2021;17:1 [Crossref]

38- Niebel D, Wenzel J, Wilsmann-Theis D, Ziob J, Wilhelmi J, Braegelmann C. Single-Center Clinico-Pathological Case Study of 19 Patients with Cutaneous Adverse Reactions Following COVID-19 Vaccines. Dermatopathology. 2021;8(4):463 [Crossref]

39- Elamin S, Hinds F, Tolland J. De novo generalized pustular psoriasis following Oxford‐AstraZeneca COVID‐19 vaccine . Clin Experimental Derm. 2022;47(1):153 [Crossref]

40- Li X, Yang X, Ning Z. Efficacy and safety of COVID-19 inactivated vaccine: A meta-analysis. Front Med. 2022;9 [Crossref]

41- Karampinis E, Gravani A, Gidarokosta P, Bogdanos D, Roussaki-Schulze A, Zafiriou E. Pustular Eruption following COVID-19 Vaccination: A Narrative Case-Based Review. Vaccines. 2023;11(8):1298 [Crossref]

42- Zhao Z, Zhang X, Wang R, Wang Y, Gong L, Li C. Vaccine‐induced erythrodermic psoriasis in a child successfully treated with secukinumab: A case report and brief literature review. Dermatologic Therapy. 2022;35(9) [Crossref]

43- Fang W, Chiu L, Hu S. Psoriasis exacerbation after first dose of AstraZeneca coronavirus disease 2019 vaccine. The Journal of Dermatology. 2021;48(11) [Crossref]

44- Rosi E, Fastame M, Di Cesare A, Silvi G, Pimpinelli N, Prignano F. Skin Manifestations in Psoriatic and HS Patients in Treatment with Biologicals during the COVID-19 Pandemic. JCM. 2021;10(24):5841 [Crossref]

45- Avallone G, Quaglino P, Cavallo F, Roccuzzo G, Ribero S, Zalaudek I, Conforti C. SARS‐CoV‐2 vaccine‐related cutaneous manifestations: a systematic review. Int J Dermatology. 2022;61(10):1187 [Crossref]

46- Graceffa D, Sperati F, Bonifati C, Spoletini G, Lora V, Pimpinelli F, Pontone M, Pellini R, Di Bella O, Morrone A, Cristaudo A. Immunogenicity of three doses of anti-SARS-CoV-2 BNT162b2 vaccine in psoriasis patients treated with biologics. Front Med. 2022;9 [Crossref]

47- Washrawirul C, Triwatcharikorn J, Phannajit J, Ullman M, Susantitaphong P, Rerknimitr P. Global prevalence and clinical manifestations of cutaneous adverse reactions following COVID‐19 vaccination: A systematic review and meta‐analysis. Acad Dermatol Venereol. 2022;36(11):1947 [Crossref]

48- Piccolo V, Russo T, Mazzatenta C, Bassi A, Argenziano G, Cutrone M, Danielsson Darlington M, Grimalt R. COVID vaccine‐induced pustular psoriasis in patients with previous plaque type psoriasis. Acad Dermatol Venereol. 2022;36(5) [Crossref]

49- Lu J, Shi Y. A review of disease burden and clinical management for generalized pustular psoriasis in China. Expert Review of Clinical Immunology. 2022;18(10):1023 [Crossref]

50- Infimate D, Yumnam D, Galagali S, Kabi A, Kaeley N. Psoriasis Flare-Up After COVAXIN BBV152 Whole Virion Inactivated Vaccine. 2022; [Crossref]

51- Kusano M, Mukaiyama R, Yamamoto T. A case of generalized pustular psoriasis following Moderna/NIAID COVID-19 vaccination successfully treated with secukinumab. Anais Brasileiros de Dermatologia. 2024;99(5):773 [Crossref]

52- Bresler S, Menge T, Tejasvi T, Carty S, Hristov A. Two cases of challenging cutaneous lymphoid infiltrates presenting in the context of COVID‐19 vaccination: A reactive lymphomatoid papulosis‐like eruption and a bona fide lymphoma. J Cutan Pathol. 2023;50(3):213 [Crossref]

53- Tachibana K, Kawakami Y, Tokuda M, Sato S, Sugihara S, Miyake T, Sugiura K, Morizane S. Flare‐up of generalized pustular psoriasis following Pfizer‐BioNTech BNT162b2 mRNA COVID‐19 vaccine: Two cases without mutations of IL36RN and CARD14 genes. The Journal of Dermatology. 2022;49(10) [Crossref]